Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Humira

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humira was produced by AbbVie and Eisai.

Allergan investors back AbbVie deal, but is a tax charge looming?

Allergan investors back AbbVie deal, but is a tax charge looming?

The merger agreement came as AbbVie is facing pressure to diversify its portfolio and reduce its reliance on blockbuster drug Humira (adalimumab) – currently the world’s best-selling medicine – which is ... AbbVie says the deal adds $16bn in annual

In a U-turn, ICER takes more positive view of AbbVie’s Rinvoq

In a U-turn, ICER takes more positive view of AbbVie’s Rinvoq The finding dented AbbVie’s hopes of growing sales of Rinvoq to offset the anticipated loss of Humira revenues to biosimilar competitors. ... ICER now calculates that the cost per month in remission on Rinvoq compared to Humira is $600.

J&J's Tremfya filed for approval in US for psoriatic arthritis

J&J's Tremfya filed for approval in US for psoriatic arthritis Lilly’s Taltz has also been proved to be superior to market leader Humira (adalimumab), in reducing psoriatic arthritis activity by half, and also completely cleared patient’s skin after 24 ... AbbVie’s Humira and J&J’s Stelara have remained

AbbVie/Allergan's merger faces public opposition

AbbVie/Allergan's merger faces public opposition protection for its $20bn immunology blockbuster Humira.

Strike three for Rova-T has AbbVie cutting its losses

Strike three for Rova-T has AbbVie cutting its losses reduce its reliance on $20bn blockbuster TNF inhibitor Humira (adalimumab).

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
mXm Medical Communications

mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...

Latest intelligence

Eye for Pharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...
What is changing in cardiovascular disease care?
Paul Midgley, of Wilmington Healthcare, explores the NHS Long-term Plan’s strategy for tackling cardiovascular disease and what it means for pharma...

Infographics